University Hospital Tuebingen

This early-phase trial tests a new treatment called CD318-CAR-T cells for people with advanced pancreatic cancer that has not responded to standard therapy. The treatment involves taking a patient's own immune cells, modifying them in a lab to better recognize and attack cancer c…

This study tests whether adding the drug venetoclax to the usual pre-transplant chemotherapy can help people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) without causing more harm. About 27 adults aged 18–75 will receive this new combination befo…

This study tests whether a home-based program combining cycling with brain games can prevent worsening of daily living skills in people with Parkinson's who are at high risk for dementia. 42 participants will be randomly assigned to either the dual-task training or a control grou…

This study will test a simple score to predict which patients may become confused (delirium) after planned heart surgery. About 100 adults will be checked before surgery using memory, orientation, and frailty tests. The goal is to identify high-risk patients early so doctors can …